Skip to main content
Caplight Logo









Stratosvir

Stratosvir

Private
IngatestoneMobility, Transportation & Logisticshttps://stratosvir.com/

Last Round

VC Round

Apr 28, 2026

Total Funding Raised

$680,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Stratosvir is a biotechnology company that develops viral immunotherapy solutions to treat solid tumors and their metastases.

Sector

Mobility, Transportation & Logistics

Verticals

Aviation & Drones, Fleet Management, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

aviation softwareSaaSaviation maintenanceregulatory compliancefleet managementaviation data managementmaintenance trackingMRO softwareaircraft maintenancevertical SaaSaviation operationsdigital record-keepingaerospace software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stratosvir Comparables

Compare Stratosvir with similar companies based on industry and business-model similarity.

Stratosvir comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TrustFlight
84%
ModernHawk
81%
Aviation InterTec Services
81%

Stratosvir Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 28, 2026
GrantOct 21, 2024
SeedJun 6, 2024
Pre SeedDec 23, 2020

Key People

Founding team and executive leadership

Chris Ullman

CEO Stratosvir

Executive Team

Stratosvir Investors

Notable investors and investment history

Stratosvir investors
InvestorRounds
Deep Science VenturesPre Seed
o2h venturesSeed
Cell and Gene Therapy CatapultVC Round
Innovate UKGrant
Proven ConnectSeed
Cancer Research HorizonsSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2026

    Raised a VC Round with Cell and Gene Therapy Catapult.

  • Oct 21, 2024

    $616K raised from Innovate UK.

Stratosvir Filings

Explore SEC and related filing metadata, where available.

Stratosvir filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stratosvir's valuation, stock price, and market status.

Is Stratosvir a public or private company?

Stratosvir is a private company.

What is the current stock price of Stratosvir?

Stratosvir is a private company with no public stock price. Caplight tracks Stratosvir's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Stratosvir worth (valuation)?

Valuation information for Stratosvir is not publicly available.

Can I buy Stratosvir stock?

Stratosvir shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stratosvir's last funding round?

Stratosvir's most recent funding round was VC Round on April 28, 2026.

Who are the main investors in Stratosvir?

Key investors in Stratosvir include Deep Science Ventures, o2h ventures, Cell and Gene Therapy Catapult, Innovate UK, Proven Connect.

Will Stratosvir IPO soon?

No public IPO plans have been announced for Stratosvir.

How can I track Stratosvir secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stratosvir's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIngatestone
Employee Range5
Year Founded2020
Last FundingApr 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?